Cemiplimab (Libtayo)

cemiplimab · Regeneron Pharmaceuticals and Sanofi

Drug timelines are a Plus or Pro feature.

17 regulatory and trial events tracked for Cemiplimab (Libtayo), covering 2023-02-08 to 2026-04-22. Get the full timeline:

Most recent: Clinical Trial Update: Study of Intralesional Cemiplimab in Adult Patients With Early Stage Cutaneous Squamous Cell Carcinoma [Phase 3]